Alpha-synuclein immunoreactivity patterns in the enteric nervous system
- PMID: 26163460
- DOI: 10.1016/j.neulet.2015.07.005
Alpha-synuclein immunoreactivity patterns in the enteric nervous system
Abstract
We aimed to compare immunoreactivity patterns of four different anti-α-syn antibodies in surgical specimens of the gastrointestinal tract of Parkinson disease and control cases. Surgical specimens from stomach, small and large bowel of 6 PD cases and 12 controls were studied. Primary antibodies: anti-α-syn clone KM51, anti-phosphorylated α-syn Ser129, anti-α-syn clone 15G7 and anti-nitrated α-syn505. We found different immunoreactivity patterns: (a) coarse, Lewy-body-like aggregates labelled by the 4 antibodies and detected in 4/6 PD cases and in 1/12 controls; (b) distinct punctate cytoplasmic staining of ganglion cells labelled by anti-phosphorylated-α-syn and detected in 3/6 PD cases and 3/12 controls; (c) fine diffuse, synaptic-type staining of neural structures labelled by anti-α-syn-15G7 and anti-nitrated-α-syn505 and detected in all subjects. We conclude that different specific and non-specific immunoreactivity patterns are detected in surgical specimens of gastrointestinal tract when using different anti-α-syn antibodies, as they recognize different epitopes and states of alpha-synuclein protein. Coarse aggregates in neural structures seem to be the most promising marker for the diagnosis of Lewy-body parkinsonism when evaluating abnormal α-syn in the gastrointestinal tract.
Keywords: Alpha-synuclein; Enteric nervous system; Gastrointestinal tract; Lewy pathology; Parkinson disease.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Enteric Pathologic Manifestations of Alpha-Synucleinopathies.Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):543-548. doi: 10.1097/PAI.0000000000000613. Appl Immunohistochem Mol Morphol. 2019. PMID: 29189256 Clinical Trial.
-
Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.Acta Neuropathol Commun. 2017 Jan 5;5(1):1. doi: 10.1186/s40478-016-0408-2. Acta Neuropathol Commun. 2017. PMID: 28057070 Free PMC article.
-
Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.Mol Neurodegener. 2018 May 11;13(1):21. doi: 10.1186/s13024-018-0257-5. Mol Neurodegener. 2018. PMID: 29751824 Free PMC article.
-
Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.Mov Disord. 2014 Apr;29(4):444-50. doi: 10.1002/mds.25789. Epub 2013 Dec 26. Mov Disord. 2014. PMID: 24375496 Review.
-
Formation and development of Lewy pathology: a critical update.J Neurol. 2009 Aug;256 Suppl 3:270-9. doi: 10.1007/s00415-009-5243-y. J Neurol. 2009. PMID: 19711116 Review.
Cited by
-
Phosphorylated alpha-synuclein distribution in the colonic enteric nervous system of patients with diverticular disease.IBRO Neurosci Rep. 2025 Feb 26;18:384-388. doi: 10.1016/j.ibneur.2025.02.009. eCollection 2025 Jun. IBRO Neurosci Rep. 2025. PMID: 40115966 Free PMC article.
-
Neurons and Glia Interplay in α-Synucleinopathies.Int J Mol Sci. 2021 May 8;22(9):4994. doi: 10.3390/ijms22094994. Int J Mol Sci. 2021. PMID: 34066733 Free PMC article. Review.
-
Restoration of intestinal function in an MPTP model of Parkinson's Disease.Sci Rep. 2016 Jul 29;6:30269. doi: 10.1038/srep30269. Sci Rep. 2016. PMID: 27471168 Free PMC article.
-
Nuclear Alpha-Synuclein in Parkinson's Disease and the Malignant Transformation in Melanoma.Neurol Res Int. 2025 Jan 6;2025:1119424. doi: 10.1155/nri/1119424. eCollection 2025. Neurol Res Int. 2025. PMID: 39816956 Free PMC article.
-
Microbiome-based therapies for Parkinson's disease.Front Nutr. 2024 Nov 6;11:1496616. doi: 10.3389/fnut.2024.1496616. eCollection 2024. Front Nutr. 2024. PMID: 39568727 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous